Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Edelson Lechtzin LLP reminds investors of the upcoming July 12, 2024 deadline in the Inari Medical, Inc. (NASDAQ: NARI) Securities Fraud Class Action
-
Edelson Lechtzin LLP is investigating bringing a class action for TRC Talent Solutions data breach.
-
Edelson Lechtzin LLP is investigating bringing class claims on behalf of consumers impacted by the Affiliate Dermatologists data breach
-
Edelson Lechtzin LLP is investigating securities fraud claims on behalf of investors of Harbor Diversified, Inc. (OTC: HRBR) between May 10, 2022, and Marc
-
Investors who purchased Altimmune, Inc. stock between December 1, 2023, and April 26, 2024, have until July 5, 2024, to move for lead plaintiff.
-
Investors who purchased Inari Medical, Inc. stock (NASDAQ: NARI) between February 24, 2022, and February 28, 2024 have until July 12, to move for lead.
-
Edelson Lechtzin LLP is investigating securities fraud claims on behalf of purchasers of Sprout Social, Inc. (NASDAQ: SPT)
-
Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Affiliated Dermatologists and Dermatologic Surgeons.
-
Edelson Lechtzin LLP is investigating securities fraud claims on behalf of investors in Akero Therapeutics, Inc. (NASDAQ: AKRO)
-
Edelson Lechtzin LLP is investigating securities fraud claims investors of Malibu Boats, Inc. (NASDAQ: MBUU) between November 4, 2022-April 11, 2024